| Scorecard |
|---|
|
3 / 5 Stars
|
|
Lipper
3
3
1
5
3
|
|
Zacks Investment Research
4
(Sell)
|
|
Standard & Poor's
4 / 5 Stars
|
|
TheStreet.com
D-
(Sell)
|
Fund Holdings
The fund tracks the MSCI Europe Index with the majority of its holdings located in the United Kingdom.
Asset Allocation
| % Long | % Net | |
|---|---|---|
| Cash | 0.55 | 0.55 |
| Stocks | 0.05 | 0.05 |
| Bonds | 0.0 | 0.0 |
| Other | 0.1 | 0.1 |
| Foreign Bonds | 0.0 | 0.0 |
| Foreign Stocks | 99.31 | 99.31 |
| Convertible | 0.0 | 0.0 |
| Preferred | 0.0 | 0.0 |
Updated 12.31.2012
Top 10 Holdings
Performance as of 04.30.2013
Portfolio as of 12.31.2012
| Ticker | YTD Return % | % Net Assets | |
|---|---|---|---|
| Nestle SA | NSRGF | 9.65 | 2.91 |
| HSBC Holdings PLC | HBCYF | 4.07 | 2.68 |
| Novartis AG | NVSEF | 17.5 | 2.01 |
| Roche Holding AG | RHHVF | 23.65 | 1.98 |
| BP PLC | BPAQF | 4.81 | 1.82 |
| Royal Dutch Shell PLC Class A | RYDAF | -0.16 | 1.79 |
| Vodafone Group PLC | VODPF | 21.77 | 1.71 |
| Sanofi | SAN | --- | 1.56 |
| Total SA | FP | --- | 1.52 |
| GlaxoSmithKline PLC | GLAXF | 20.09 | 1.49 |
